Reps. Alexandria Ocasio-Cortez, Dan Crenshaw & Lou Correa Celebrate Progress in Psychedelics Treatment for PTSD

Representatives Alexandria Ocasio-Cortez (NY-14) and Dan Crenshaw (TX-02) hosted a press conference recognizing progress with a provision in the National Defense Authorization Act (NDAA) that directs the Secretary of Defense to conduct a clinical report on psychedelic treatment in military treatment facilities. Initial medical research shows promising results for the use of psychedelics in treating Post-Traumatic Stress Disorder (PTSD) and Traumatic Brain Injury (TBI). In past years, both Rep. Ocasio-Cortez and Rep. Crenshaw have separately introduced amendments to the NDAA to allow for the medical study of psychedelics. This year, a version of their amendment language was included in the original bill text for the NDAA. The NDAA, along with the psychedelics provision, is expected to pass the House on Friday. At the press conference, Reps. Ocasio-Cortez and Crenshaw were joined by Rep. Lou Correa, Co-Chair of the Congressional Psychedelics Advancing Clinical Treatments “PACT” Caucus.